Global Organ Transplant Immunosuppressant Drugs Market Set For Moderate Growth, To Reach Value around USD 5.79 Billion by 2025

18-Feb-2020 | Zion Market Research

Zion Market Research has published a new report titled “Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors); by Transplant Type (Pancreas, Lung, Heart, Liver, Kidney and Other); by Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for organ transplant immunosuppressant drugs market was valued at approximately USD 4.51 billion in 2018, and is expected to generate revenue of around USD 5.79 billion by end of 2025, growing at a CAGR of around 3.7% between 2019 and 2025.

Browse the full “Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors); by Transplant Type (Pancreas, Lung, Heart, Liver, Kidney and Other); by Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025.” Report at https://www.zionmarketresearch.com/report/organ-transplant-immunosuppressant-drugs-market

Request Sample Request Customization Buy Now

Organ transplant is a medical procedure in which recipient receives donor organ to replace damaged or missing organ. Autograft is type of transplant in which tissues or organs are transplanted within the same person’s body. Allograft is a transplant between two subjects of the same species from and is from either living or cadaveric source. Organ is usually transplanted when no other treatment works or in case of end state organ failure like heart, kidney, liver failure. During transplantation if donor and recipients are not matched, the recipient’s immune system may attack the newly transplanted organ, this phenomenon is termed as transplant rejection. Transplant rejection is relatively common and immunosuppressant drugs are prescribed to the person with transplanted organ for lifetime.

The global organ transplant immunosuppressant drugs market growth is fueled by various factors like increasing number of organ transplantations, increasing expenditure on tissue engineering R&D, and technological advancements in organ transplant. Also, growing burden of chronic disease such as diabetes, cardiovascular diseases, kidney failure etc. is another important factor driving the growth of organ transplant immunosuppressant drugs market. However, high cost of transplantation procedure and low availability of organs may impede the market growth over the forecast period.

The organ transplant immunosuppressant drugs market is segmented based on transplant type, drug class, and region. Based on drug class, global market is segmented into steroids, antibodies, antiproliferative agents, calcineurin inhibitors and mTOR inhibitor. In 2018, market was dominated by calcineurin inhibitors segment whereas fastest growth is projected for antibodies during the forecast period. Cyclosporine and tacrolimus are major drugs under calcineurin inhibitors drug class and are effectively been used for almost 20 years, thus contributing to large market share.

Based on transplant type, market is segmented into lung, pancreas, liver, heart, kidney and others. In 2018, kidney transplant was the most common transplant type worldwide. This is due to relatively easy availability of kidney donors as compared to other organs. Also, kidney transplant is more cost effective as compared to prolonged periods of dialysis.

Based on distribution channel, global organ transplant immunosuppressant drugs market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. Hospital pharmacies held leading market share in 2018 since it is most widely preferred channel of distribution.

North America represents developed regional market for organ transplant immunosuppressant drugs. Presence of favorable reimbursement policies, presence of developed healthcare facilities, technological advancements, increasing healthcare spending are major factors driving the market growth in this region. Europe was second largest market in 2018. Asia Pacific is projected to witness rapid CAGR for organ transplant immunosuppressant drugs market. Dense population base, increasing chronic disease burden, increasing healthcare expenditure, introduction of favorable reimbursement policies are expected to boost market growth in Asia Pacific. Latin America is will register noticeable growth over the forecast period. Middle East and Africa will register sluggish growth in the years to come as a result of lack of advanced healthcare infrastructure.

Major players included in the report are Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Mylan Laboratories, Inc., Novartis AG, Accord Healthcare Ltd., Sanofi Genzyme, and Astellas Pharma, Inc. among others.

The report segment of global organ transplant immunosuppressant drugs market as follows:

Global Organ Transplant Immunosuppressant Drugs Market: By Drug Class

  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • mTOR Inhibitor
  • Steroids
  • Antibodies

Global Organ Transplant Immunosuppressant Drugs Market: By Transplant Type

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
  • Other

Global Organ Transplant Immunosuppressant Drugs Market: By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Organ Transplant Immunosuppressant Drugs Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Request Brochure
Latest Published Reports

View All Published Reports